期刊文献+

经尿道等离子双极电切治疗高危良性前列腺增生 被引量:6

Transurethral resection of high-risk benign prostatic hyperplasia using bipolar plasmakinetic technique
下载PDF
导出
摘要 目的探讨经尿道双极等离子电切术(PKRP)治疗高危良性前列腺增生(BPH)的临床效果和安全性。方法回顾性分析经尿道双极等离子电切术治疗159例高危BPH患者的疗效。结果159例患者均1次顺利完成手术,无经尿道前列腺电切术(TURP)综合征及闭孔神经反射发生,PKRP手术时间平均45(s=23)min,切除前列腺组织质量平均30(s=28)g。出血量平均43(s=32)mL,术后48 h内拔除尿管,排尿均通畅。术后1、3、6、12个月,最大尿流率(Qmax)由术前的平均4.9(s=4.1)mL/s分别上升至17.6(s=4.5)、20.6(s=4.7)、21.3(s=5.5)、22.4(s=5.3)mL/s;国际前列腺症状评分(IPSS)由术前的平均23.7(s=3.28)分别下降至7.1(s=2.21)、6.3(s=2.15)、6.0(s=2.03)、5.6(s=2.00);生活质量评分术后均下降(P均〈0.05)。平均随访8(6-12)个月,尿道狭窄1例,暂时性尿失禁11例。无1例发生真性尿失禁。结论等离子双极电切行经尿道前列腺切除是一种安全、有效的手术方式,其操作方式、切除速度与传统TUR手术相似,而且具有止血效果好、使用生理盐水为冲洗液、无须负极板、手术创伤轻,并发症少等优点,可推广应用于高危前列腺增生症患者。 Objective To assess the clinical efficacy and safety of transurethral resection of the prostate(PKRP) with plasmakinetic technique. Methods A total of 159 patients with high - risk benign prostatic hyperplasia (BPH) and being treated by PKRP were analyzed retrospectively. Results The duration of the PKRP procedure was 45 ( s = 23) rain. No transure'thral resection (TURP) syndrome and abjuratory reflex occurred. The volume of intraoperative bleeding was 43 ( s = 32) mL. Peak urine flow increased from 4.9 ( s = 4.1 ) mL/s to 17.6 ( s = 4.5) mL/s, P 〈 0.05, and IPSS decreased from 23.7 (s =3.28) to 6.3 (s =2.15, P〈0.01, in 3 months postoperatively. No residual urine occurred after the operation. Conclusions PKRP is effective and safe with less complication. It can be extend to cure high-risk hyperplasia of prostate.
出处 《中国校医》 2007年第3期319-321,共3页 Chinese Journal of School Doctor
关键词 前列腺增生 经尿道前列腺切除 Prostatic Hyperplasia Transurethral Resection of Prostate
  • 相关文献

参考文献5

二级参考文献10

  • 1叶敏,张良,陈建华,孔良,王伟明,马邦一,蒋鹤鸣.经尿道前列腺电汽化术治疗前列腺增生症[J].中华泌尿外科杂志,1997,18(7):417-420. 被引量:190
  • 2[1]Mcbust W K,Holtgrewe H L,Cockett A T K,et al.Transurethral prostatectomy; Immediate and postoper ative complications. Axooperative study of thirteen par ticipating institution evaluating 3885 patients . J Urol,1989,141: 243- 247.
  • 3[2]Evans J, Singer M,Coppinger S, et al. Cardiovascular performance and core temperature during transurethral prostatectomy. J Urol, 1994,152,2025 2028.
  • 4[3]Freedman M, van Molen S W, Makings E. Blood loss measurement during transurethral resection of the prostate gland. Br J Uro1,1985,57:311-314.
  • 5[4]Ekengren J ,Hahn R G. Blood loss during transurethral resection of the prostate as measured by the hemochrome photometer. J Urol, 1993,42: 501 - 505.
  • 6[5]Narayan P,Tewari A, Croker, et al. Factors affecting sizes and configuration of electrovaporization lesions ing th the prostate. J Uro1,1996,47:679-683.
  • 7[6]Elengren J, Hmhn R G. Complications during transurethral aporization. Urology, 1996,48: 424- 427.
  • 8[7]Henry B,Barre P. Electro-vaporisation of the prostate with the gyrus device. Eur Urol, 2000,37 (Suppl 2): 1 -175.
  • 9[8]Virdi,Faiyaz K, Ponnambalam Chandrasekar, et al. A prospectiverandomised study between transurethral va porisation using plasmakinetic energy. J Urol , 163(Suppl) :268-271.
  • 10[9]Lefaucheur J P, Yiou R,Salomon L,et al. Abbou-CC assessment of penile small nerve fiber damage after transurethral resection of the prostate by measurement of penile thermal sensation. J Urol,2000, 164: 1416-1419.

共引文献444

同被引文献36

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部